These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8336652)
1. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 2. Patient treatment]. Sergiev VP; Shuĭkina EE; Kuznetsov VP; Beliaev DL; Fediainova IE; Norbadalov MT; Suntsov SN Med Parazitol (Mosk); 1993; (1):42-3. PubMed ID: 8336652 [TBL] [Abstract][Full Text] [Related]
2. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 1. Research on an experimental model in mice]. Shuĭkina EE; Sergiev VP; Kuznetsov VP; Beliaev DL; Fediainova IE Med Parazitol (Mosk); 1993; (2):28-31. PubMed ID: 8028564 [TBL] [Abstract][Full Text] [Related]
3. [Repeated infections with zoonotic cutaneous leishmaniasis after treatment with monomycin]. Sergiev VP Med Parazitol (Mosk); 1974; 43(5):598-9. PubMed ID: 4281871 [No Abstract] [Full Text] [Related]
4. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis. Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655 [TBL] [Abstract][Full Text] [Related]
5. [The use of leukinferon in treating measles in adult patients]. Nikolaeva IN; Kuznetsov VP; Barer GM; Parkhomenko IuG; Beliaev DL; Sinitsyna OV; Babaiants AA; Iushchuk ND Stomatologiia (Mosk); 1995; 74(3):32-5. PubMed ID: 7570694 [TBL] [Abstract][Full Text] [Related]
6. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Sadeghian G; Nilforoushzadeh MA Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518 [TBL] [Abstract][Full Text] [Related]
7. [Leukinferon in the treatment of patients with acute viral hepatitis b]. Golban TD; Cheshin SG; Kuznetsov VP; Farber NA; Beliaev DL; Kirzhner LS; Babaiants AA; Vasina VI Klin Med (Mosk); 1994; 72(3):27-9. PubMed ID: 7990347 [TBL] [Abstract][Full Text] [Related]
8. [Results of monomycin treatment of rural type cutaneous leishmaniasis]. Arustamian TA; Magdieva SR; Muradullaev GM; Shishkov NI; Pazylov TP; Gavrilova EE Med Parazitol (Mosk); 1967; 36(1):75-9. PubMed ID: 4237691 [No Abstract] [Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
10. [Properties of a collagen and monomycin complex]. Rudenko TG; Dronov AF; Arutiunova VA; Vaisov ASh Antibiotiki; 1977 Mar; 22(3):239-42. PubMed ID: 322605 [TBL] [Abstract][Full Text] [Related]
11. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis. Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071 [TBL] [Abstract][Full Text] [Related]
12. Untreated zoonotic cutaneous leishmaniasis characterizing a highly aggressive strain type of Leishmania major in Uzbekistan. Faulde MK; Werner A; Heyl G J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1432-3. PubMed ID: 17958865 [No Abstract] [Full Text] [Related]
13. [The clinical efficacy in using leukinferon in adults with diseases caused by the varicella-zoster virus]. Kuznetsov VP; Nikolaeva IN; Barer GM; Beliaev DL; Sundukov AV; Babaiants AA; Iushchuk ND Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):72-5. PubMed ID: 9381878 [TBL] [Abstract][Full Text] [Related]
14. [Monomycin therapy of patients with acute necrotizing cutaneous leishmaniasis]. Arustamian TA Vestn Dermatol Venerol; 1967 Oct; 41(10):45-9. PubMed ID: 4901528 [No Abstract] [Full Text] [Related]
15. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452 [TBL] [Abstract][Full Text] [Related]
16. [Use of leukinferon for prophylaxis of pyogenic complications in victims with thoracic wounds]. Bulava GV; Abakumov MM; Druzenko OA; Markova OA; Pogodina AN; Khvatov VB Khirurgiia (Mosk); 1999; (7):35-9. PubMed ID: 10459185 [TBL] [Abstract][Full Text] [Related]
17. [The effect of injectable leukinferon on the immune reactivity of patients with steroid-dependent bronchial asthma]. Marinin VF; Andriukin AA; Kuznetsov VP; Nastiukova EG; Dudkina LN; Niaĭkina NIu; Beliaev DL Ter Arkh; 1990; 62(3):95-7. PubMed ID: 2368008 [TBL] [Abstract][Full Text] [Related]
18. Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. Lobo IM; Soares MB; Correia TM; de Freitas LA; Oliveira MI; Nakatani M; Netto E; Badaro R; David JR Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):642-9. PubMed ID: 16274713 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Sadeghian G; Nilfroushzadeh MA; Iraji F Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205 [TBL] [Abstract][Full Text] [Related]
20. [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period]. Bassalyk LS; Shoshiashvili VD; Kushlinskiĭ NE; Mistakopulo NF; Kuznetsov VP; Rylov VV; Liakina LT Vopr Onkol; 1992; 38(5):555-61. PubMed ID: 1300754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]